National Cancer Institute Breast Cancer Steering Committee working group report on meaningful and appropriate end points for clinical trials in metastatic breast cancer

Andrew D. Seidman, Louise Bordeleau, Louis Fehrenbacher, William E. Barlow, Jane Perlmutter, Lawrence Rubinstein, Suparna B. Wedam, Dawn L. Hershman, Jennifer Fallas Hayes, Lynn Pearson Butler, Mary Lou Smith, Meredith M. Regan, Julia A. Beaver, Laleh Amiri-Kordestani, Priya Rastogi, Jo Anne Zujewski, Larissa A. Korde

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'National Cancer Institute Breast Cancer Steering Committee working group report on meaningful and appropriate end points for clinical trials in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences